All.Can International in Farmacista33 magazine

Link to the full article: www.farmacista33.it/politica-sanitaria/30299/revisione-della-pharma-legislation-equilibrio-tra-innovazione-e-accesso.html 

Posted on:

Related reading

Advancing Global Cancer Policy at the UICC World Cancer Leaders’ Summit 2025

All.Can International joined global leaders at the UICC World Cancer Leaders’ Summit 2025 in Melbourne from 18-20 November 2025 to promote early cancer care, women’s health equity and efficient, person-centred cancer systems.

Pictured left to right: All.Can past President Alex Filicevas, All.Can current President Christobel Saunders, All.Can Board member Michael Oberreiter

Read more

All.Can contributes to new Lancet Oncology recommendations calling for timely, efficient and accountable cancer care in the UK

All.Can is proud to have supported the development of a newly published Lancet Oncology article, “A deliverable national cancer control plan for…

Read more

All.Can insights contribute to European and regional policy on cancer care efficiency

All.Can’s work continues to inform the policy dialogue on how to make cancer care more efficient and person-centred. Recent European and regional…

Read more